Interstitial irradiation of the pituitary gland for advanced carcinoma of the breast using the trans-ethmoidal approach. by Greening, W. P. & Thompson, S. G.
703
INTERSTITIAL IRRADIATION OF THE PITUITARY GLAND FOR
ADVANCED CARCINOMA OF THE BREAST USING THE TRANS-
ETHMOIDAL APPROACH
W. P. GREENING AND S. GRAHAM THOMPSON
From the Royal Marsden Hospital, London
Received for publication August 18, 1966
BETWEEN the years 1955 and 1958, 100 patients suffering from advanced
metastatic carcinoma of the breast were treated at the Royal Marsden Hospital
by interstitial irradiation ofthe pituitary, using a radioactive source in the form of
gold or yttrium. In these cases the trans-nasal route was employed with radio-
logical control, using the image intensifier (Greening et al., 1960).
With this method, a high percentage of complications occurred, namely
rhinorrhoea (21%), meningitis (10%) and visual disturbances (3 Oo). It is the
purpose ofthis paper to analyse a further series of cases treated during the period
1957-64, using the trans-ethmoidal route.
METHOD
Cortisone replacement is started 48 hours before the procedure is carried out,
also a prophylactic course of sulphadimidine. The actual procedure has been
described in detail by other authors (Bauer et al., 1956), but during the latter part
of the years under review certain modifications have been made. These consist,
firstly, of an outer sheath which is inserted with the Bauer needle. This sheath
does not enter the sella turcica, but abuts on the puncture hole, made in the latter
by the sharp tip of the needle which itself enters the fossa. After the radioactive
material has been deposited in the fossa the needle is withdrawn, leaving the
sheath; a small nylon plug is then passed down the latter before withdrawing the
sheath. Each plug has a minute core of gold wire which is visible on the radio-
graph and shows that the plug is sited correctly (Figs. 1 and 2).
Under general anaesthesia the needle, with its sheath, is tapped into the
lachrymal bone immediately medial to the inner canthus ofthe eye (usually on the
right side), taking care to avoid the anterior facial vein. It is important that the
needle enters the lachrymal bone; if a slightly higher position is selected in error,
the nasal process of the frontal bone will be encountered, and this will cause some
difficulty owing to its thickness. The head is kept strictly in the midline, and the
whole procedure is under two-plane radiographic control with the image intensi-
fier. A good degree of accuracy can be obtained in placement of the radioactive
material, and the whole operation does not usually last more than 15 minutes.
MATERIAL
Forty-two cases of advanced disseminated, carcinoma of the breast were
treated by the trans-ethmoidal route during the period 1958-64. After the
previous review (Greening et al., 1960) in which attention was drawn to the risk ofW. P. GREENING AND S. GRAHAM THOMPSON
complications when the trans-nasal route is employed, the procedure was aban-
doned (or carried out less commonly) until the trans-ethmoidal route was insti-
tuted, and this accounts for the smaller number during the period 1958-64.
Age
The average age at which the procedure was carried out was 56 the youngest
being 39 and the oldest 73. The approximate average time between the first
consultation for the disease and the implantation was 41 years, the longest time
being 15 years, when the patient was aged 64. Five patients, including the last,
are still alive, the longest period since the implant being two years.
Previous treatment
Exactly half (22) ofthese patients had undergone previous oophorectomy, and
in 4 cases bilateral adrenalectomy had also been carried out. Fourteen patients
had received androgen therapy, 11 oestrogen therapy, and 5, a course of metho-
trexate before the pituitary implant. Only 3 of those who received androgens,
one of those who received oestrogens, and none of those who were treated with
methotrexate, were noted to be improved at all for any length oftime beforehand.
It is interesting to note that those who had undergone previous oophorectomy
appeared to survive longer (15.6 months) after the implant, as against those who
still retained ovaries and adrenals (7.8 months). This is still further interesting
in that the former group were proportionately younger and therefore the disease
could be expected to pursue a more rapid course.
Complscations
Compared to the previous series, this group is notable for its freedom from
complications andlack ofdistress to the patients (Table I). Only 3 had complica-
TABLE I.-Complications ofMethodsfor Implantation
Complications
Diabetes
insipidus
Visual (lasting
No. of Rhinor- Menin- distur- more than Haemor-
Series Route patients rhoea gitis bances 2 weeks) rhage
R.M.H. . Trans- . 42 . 1 nil 1 nil 1
(present series) ethmoidal
R.M.H. . Trans- . 100 . 21 10 3 nil 2
(Ramsay, 1960) nasal
Udvarhelyi . Trans- . 30 . 5 3 not stated
(1962) nasal
Forrest et al. . Trans- . 171 . 7 4 7 not stated
(1959) nasal
(screw)
Desaive etat. Trans- . 87 . 2 nil 2 nil
(1964) ethmoidal
EXPLANATION OF PLATE
FIG. 1.-Modified Bauer needle, showing component parts and nylon plug.
FIG. 2.-Modified Bauer needle-assembled, with obturator.
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tions directly attributable to the procedure; one had rhinorrhloea which ceased
after 2 weeks; one had surgical emphysema and proptosis of the orbit which
lasted 2 weeks' and the remaining patient, who was in ani extremely poor
condition at operation and who died 3 weeks later, was found at post-mortem to
have haemorrhage and blood clot surrounding the pituitary fossa. No cases of
meninigitis or persistent rhinorrhoea were recorded. One patient died a week
later from massive pulmonary infection. Indeed, it is often the presence of
extensive pulmonary metastases or pleural effusions which preclude the adminis-
tration of a general anaesthetic which is necessary for the implantation to be
carried out. Transient headache and/or diabetes insipidus was recorded in a few
patients, but this did not persist longer than a week and no patient was unduly
distressed by the procedure.
In thle previous series the completeness of destruction was investigated by
estimating the urinary gonadtrophin level (HMG) and there appears to be some
correlation with the percentage destruction of the gland and a fall in the urinary
HMG units ill some cases, though this is by no means always comparable with the
amount destroyed. In the present series the HMG levels were estimated in 25
cases before and after the implant and all except one case recorded a fall (Fig. 3).
Sprunit et al (1963) describe an improved method using metyrpone, which they
consider is a more accurate index of the completeness of destruction.
Post mortema findings
It was possible to obtain post mortem examinations on only 9 of the cases in
this series and the results are set out in Table II. The position of the radioactive
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FIG. 3. Fall in gonadotrophin level after pituitary implant.
(In one case the level rose.)
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TABLE II.-Post Mortem Assessment
Approx. %
destruction HMG units
Isotope at post- Survival
Patient and dosage Position mortem (months) Before After
1. .O 8y 5 9mc Good . 95 . 12 54 23
2. .90Y 8-3 mc . Good 80 . 5 . 98 32
3. . 98Au 10-4 mc . Good . 95 . 4 . 62 12
4. . "8Au 29 5mc . Moderate . 20 . 2 135 40
5. 9OY 8-7 mc . Good . 100 . Died of Not recorded
pulmonary
infection
2 weeks later
6. 9 "8Au 30 9 mc . Good . 75 Diedof . 95 60
pulmonary
embolus
1 month later
7. .9Y 12-6mc . Good . 100 . 3 . Not recorded
8. 198Au 55 5 mc . Poor . 50 2 . 25 14
9. .98Au 30 mc . Moderate . 60 . 4 . 88 52
material was assessed on radiographs ofthe skull at the conclusion of the implant
and described arbitrarily as " good ", " moderate ", or " poor " positioning.
Similarly on histological sectioning a naked eye assessment of the amount des-
troyed was done on a percentage basis (Table II).
RESULTS
The average duration of survival after implant is 10-9 months for gold and
9*7 months for yttrium, the overall average of survival being 10-3 months. The
longest survival recorded after implant during this period is 6 years, before she
eventually died from multiple metastases. Symptomatic improvement, especi-
ally for bone pain was noted for varying periods soon after the procedure in 16
patients (38%) and objective improvement in 9 patients (21%). Of the latter,
7 had undergone previous oophorectomy (but none had had adrenalectomy), and
the remaining two were postmenopausal, both being aged over 60. Of these 9
patients 5 appeared to have a preponderance of bony metastases, and 4 mostly
visceral metastases. Nine other patients underwent further treatment after the
pituitary implant, and the results are summarised in Table III. Over the whole
TABLE III.-Further Treatment after Pituitary Implantation
Patient Type oftherapy Survival (months)
1. . Irradiated autovaccine . Still alive 15 months
from tumour of breast after pituitary implant
2. . Methotrexate . 2
3. . Methotrexate . 36
4. . Methotrexate . 10
5. . Methotrexate . 7
6. . Chlorambucil . 12
7. Chlorambucil . 5
8. . Testosterone . 14
9. . Testosterone . 24
series of 42 patients the average survival for a preponderance of visceral meta-
stases was 9-9 months, although it will be realised that the latter subdivision is
somewhat arbitrary.IRRADIATION OF THE PITUITARY GLAND
Comparison with other procedures
Disregarding survival rates, this figure of 38% for improvement in symptoms
compares favourably with other methods of treatment, and in a previous series of
122 patients (reviewed by Harmer in 1957, personal communication) treated by
adrenalectomy at the Royal Marsden Hospital, 42-5% were improved sympto-
matically. His review totalled 359 patients and included series from other
hospitals, and the overall figure for improvement was 4500. Harmer points out
the difficulty of assessing subjective, as against objective improvement, and this
figure of 4500 represents a mean. Hypophysectomy is not carried out at the
Royal Marsden Hospital, so there are no figures available for comparison.
DISCUSSION
Three routes are at present available for implanting radioactive material into
the pituitary fossa, namely trans-ethmoidal (Bauer, 1956), trans-nasal (Henderson,
1938) and trans-cranial (Rasmussen et al., 1953; Evans et al., 1959) and on
reviewing the literature it appears that the first is the most popular, besides being
the simplest and one least likely to cause complications and distress to the patient.
The trans-ethmoidal route was pioneered by Bauer (1956) and Greening et al.
(1960) commented at the conclusion of their review that theoretically it seemed a
more satisfactory route than the nasal one and antibiotic cover would not be
necessary, although it has been the practice at the Royal Marsden Hospital to
administer a prophylactic course ofsulphadimidine to all cases who are to undergo
this procedure.
With regard to the relative effectiveness of gold or yttrium, the latter is
theoretically a better isotope as the tissue dose is higher, but the fall-off is rapid
and it therefore requires more critical placement. Gold is probably preferable for
lesions where the periphery of the gland is required to be destroyed in addition to
the centre, and where alarge mass ofpituitary tissueisinvolved, e.g. in acromegaly.
Review of literature
Udvarhelyi (1962) using 198Au on 30 patients via the trans-nasal route obtained
an average survival time of 3-1 months and subjective improvement in two thirds
ofthe cases; most ofthese patients had bony metastases. Rhinorrhoea occurred
in 5 of his patients and 3 developed meningitis. He used a fairly large dose,
varying between 23-45 mc of unscreened '98Au and by post-mortem studies
decided that this did not achieve total destruction of the pituitary.
Juret and Haymen (1961) used gold on 30 cases with poor results and yttrium
on 45 cases with both clinical and radiological improvement in bony metastases.
Ruches (1960) used a very large dose of 198Au (100 mc) in 3 cases, using about a
dozen seeds and obtained complete necrosis in only one case at post-mortem.
Frey and C(occhi (1959) concluded that even with accurate placement of 4 gold
seeds delivering a dose of 40 mc, it is impossible to destroy the whole pituitary
gland. However, Peter et al. (1963) used gold on 28 patients and found that 16
benefited (6 more than 6 months). Rand et al. (1962) using a stereotactic instru-
ment and yttrium on 25 patients obtained a clinically complete hypophysectomy
in 13 cases, and Bucalossi et al. (1960) thought pituitary irradiation by the trans-
ethmoidal route comparable to a surgical hypophysectomy without the complica-
tions of the latter. Talairach et al. (1956) packs the sella with yttrium so that no
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part ofthe gland is theorectically left undestroyed, and Blair (1963) using a screw
containing 90Y on 36 patients via the trans-nasal route obtained 90% destruction
with accurate placing. His cases were aged between 40 and 81 and consisted of
both visceral and bony metastases. The results were not assessed but he com-
ments that 14 developed diabetes insipidus treated by pitressin, but that only one
developed rhinorrhoea which necessitated a muscle graft. He emphasizes that
extensive metastases in the skull are a contra-indication to pituitary implantation
as rhinorrhoea is likely to develop. Desaive et al. (1964) using radioactive gold
and the trans-ethmoidal route was impressed with the paucity of postoperative
complications; in 87 patients, of which 32 were suffering from carcinoma of the
breast, only 2 were complicated byrhinorrhoea, 2 by visual disturbances, and 6 by
diabetes insipidus, which was easily controlled by posterior pituitary extract.
Forrest et al. (1959) obtained virtually complete destruction ofthe pituitary using
a large dose ofyttrium (14mc) but noted that with a larger dose ofthe isotope the
risk of visual disturbance and diabetes insipidus is greater. The same authors in
a later communication (1964) review 171 cases using 90Y in a screw via the trans-
nasal route and obtained up to 95% destruction; ofthese cases 2% suffered with
visual defects postoperatively, 4.5% rhinorrhoea, 2% extra-ocular palsy, and 2%
meningitis. They compared 66 patients who underwent pituitary implant with
72 patients who underwent adrenalectomy and oophorectomy alone; there was
virtually no difference in theregression rate, which was 35% for the first group and
36% for the latter group.
In our series we obtained an overall average survival time of 10-3 months which
compares favourably with other workers' results. Udvarhelyi (1962) obtained a
survival time ofjust over 3 months, Escher and Ludi (1961) 18-7 months, Boesen
et al. (1961) about 12 months. Most workers noted a marked improvement in
bony pain and this was found in a fair proportion of our cases, but Frey and
Cocchi (1959) state that in their series visceral metastases were unaffected though
in our cases they appeared to survive slightly longer than those with bony meta-
stases. The same author found a dramatic relief of bony pain after the implant
and this was also confirmed by Mewissen et al. (1962). However, Escher and
Ludi state that those patients with cerebral metastases do badly with this form of
treatment. On the whole surgical hypophysectomy appears to be a more effective
method ofpituitary destruction, though the operative mortality is high compared
with interstitial irradiation. In agreement with our findings Escher and Ludi
remark that better results were obtained ifoophorectomy is performed before the
pituitary implant. Other workers (Boesen et al., Forrest et al.) note that patients
have a greater chance of remission when there has been a previous favourable
response to other forms of endocrine surgery. Peter et al. (1963) suggest that in
order to improve results it is necessary to implant at an earlier stage ofthe disease.
Many of these patients are in the terminal stage of the disease when pituitary
implantation is carried out, andwhen there is no other form oftreatment available
to offer the patient; this undoubtedly gives a poor impression when assessing the
results of the procedure, though most authors agree that the subjective relief
obtained by the procedure is worthwhile and lasts for a fair time.
SUMMARY
Forty-two cases of advanced carcinoma of the breast which were treated by
trans-ethmoidal implantation of the pituitary gland with radioactive gold or
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yttrium are reviewed. In only three of these did complications occur, and were
temporary in two; no cases of meningitis occurred. The average duration of
survival after the implant was 10-3 months and sixteen patients (38%) were
improved symptomatically by the procedure. The recent literature is reviewed
and the advantages of the transethmoidal route are discussed.
The authors are indebted to Mr. S. W. Vince, ofthe Photographic Department,
and Miss L. Pegus, of the Art Department, Royal Marsden Hospital, for the
illustrations; and to Miss I. McKinnon, Royal Marsden Hospital, for secretarial
assistance.
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